These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection. Cross TJ; Quaglia A; Hughes S; Joshi D; Harrison PM J Viral Hepat; 2009 Jul; 16(7):492-9. PubMed ID: 19200134 [TBL] [Abstract][Full Text] [Related]
3. [Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection]. Stránský J; Ryzlová M; Striteský J; Horák J Vnitr Lek; 2002 Oct; 48(10):924-8. PubMed ID: 16737138 [TBL] [Abstract][Full Text] [Related]
4. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India. Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460 [TBL] [Abstract][Full Text] [Related]
5. Progression of liver fibrosis among injection drug users with chronic hepatitis C. Wilson LE; Torbenson M; Astemborski J; Faruki H; Spoler C; Rai R; Mehta S; Kirk GD; Nelson K; Afdhal N; Thomas DL Hepatology; 2006 Apr; 43(4):788-95. PubMed ID: 16557548 [TBL] [Abstract][Full Text] [Related]
6. Risk factors for fibrosis progression in HIV/HCV coinfected patients from a retrospective analysis of liver biopsies in 1985-2002. Schiavini M; Angeli E; Mainini A; Zerbi P; Duca PG; Gubertini G; Vago L; Fociani P; Giorgi R; Cargnel A HIV Med; 2006 Jul; 7(5):331-7. PubMed ID: 16945079 [TBL] [Abstract][Full Text] [Related]
7. Risk factors for hepatitis C fibrosis: a prospective study of United States veterans compared with nonveterans. Kayali Z; Tan S; Shinkunas L; Voigt M; LaBrecque DR; Stapleton JT; Brown KE; Schmidt WN J Viral Hepat; 2007 Jan; 14(1):11-21. PubMed ID: 17212639 [TBL] [Abstract][Full Text] [Related]
8. Assessment of fibrosis progression in untreated irish women with chronic hepatitis C contracted from immunoglobulin anti-D. Levine RA; Sanderson SO; Ploutz-Snyder R; Murray F; Kay E; Hegarty J; Nolan N; Kelleher D; McDonald G; O'Keane JC; Crowe J Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1271-7. PubMed ID: 16901770 [TBL] [Abstract][Full Text] [Related]
9. Contribution of obesity to hepatitis C-related fibrosis progression. Ortiz V; Berenguer M; Rayón JM; Carrasco D; Berenguer J Am J Gastroenterol; 2002 Sep; 97(9):2408-14. PubMed ID: 12358265 [TBL] [Abstract][Full Text] [Related]
10. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C. D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534 [TBL] [Abstract][Full Text] [Related]
11. Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults. Sulkowski MS; Mehta SH; Torbenson MS; Higgins Y; Brinkley SC; de Oca RM; Moore RD; Afdhal NH; Thomas DL AIDS; 2007 Oct; 21(16):2209-16. PubMed ID: 18090048 [TBL] [Abstract][Full Text] [Related]
12. Fibrosis progression in initially mild chronic hepatitis C. Boccato S; Pistis R; Noventa F; Guido M; Benvegnù L; Alberti A J Viral Hepat; 2006 May; 13(5):297-302. PubMed ID: 16637859 [TBL] [Abstract][Full Text] [Related]
13. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection? Sanai FM; Benmousa A; Al-Hussaini H; Ashraf S; Alhafi O; Abdo AA; Alameri HF; Akbar HO; Bzeizi KI Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520 [TBL] [Abstract][Full Text] [Related]
14. Progression of fibrosis in chronic hepatitis C. Ghany MG; Kleiner DE; Alter H; Doo E; Khokar F; Promrat K; Herion D; Park Y; Liang TJ; Hoofnagle JH Gastroenterology; 2003 Jan; 124(1):97-104. PubMed ID: 12512034 [TBL] [Abstract][Full Text] [Related]
15. Predictive factors for the severity of liver fibrosis in patients with chronic hepatitis C and moderate alcohol consumption. Vădan R; Gheorghe L; Becheanu G; Iacob R; Iacob S; Gheorghe C Rom J Gastroenterol; 2003 Sep; 12(3):183-7. PubMed ID: 14502317 [TBL] [Abstract][Full Text] [Related]
16. Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation. Sterling RK; Sanyal AJ; Luketic VA; Stravitz RT; King AL; Post AB; Mills AS; Contos MJ; Shiffman ML Am J Gastroenterol; 1999 Dec; 94(12):3576-82. PubMed ID: 10606322 [TBL] [Abstract][Full Text] [Related]
17. Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase. Sánchez-Conde M; Berenguer J; Miralles P; Alvarez F; Carlos Lopez J; Cosin J; Pilar C; Ramirez M; Gutierrez I; Alvarez E Clin Infect Dis; 2006 Sep; 43(5):640-4. PubMed ID: 16886160 [TBL] [Abstract][Full Text] [Related]
18. Progression of initially mild hepatic fibrosis in patients with chronic hepatitis C infection. Williams MJ; Lang-Lenton M; J Viral Hepat; 2011 Jan; 18(1):17-22. PubMed ID: 20088889 [TBL] [Abstract][Full Text] [Related]
19. Documented rapid course of hepatic fibrosis between two biopsies in patients coinfected by HIV and HCV despite high CD4 cell count. Bonnard P; Lescure FX; Amiel C; Guiard-Schmid JB; Callard P; Gharakhanian S; Pialoux G J Viral Hepat; 2007 Nov; 14(11):806-11. PubMed ID: 17927617 [TBL] [Abstract][Full Text] [Related]
20. Inverse association between hepatic stellate cell apoptosis and fibrosis in chronic hepatitis C virus infection. Gonzalez SA; Fiel MI; Sauk J; Canchis PW; Liu RC; Chiriboga L; Yee HT; Jacobson IM; Talal AH J Viral Hepat; 2009 Feb; 16(2):141-8. PubMed ID: 19175868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]